Bispecific fibrous glue synergistically boosts vascular normalization and antitumor immunity for advanced renal carcinoma therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bispecific fibrous glue synergistically boosts vascular normalization and antitumor immunity for advanced renal carcinoma therapy

Published:2024-07 Issue: Volume:308 Page:122550
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Wu Xiu-Hai,Wang Jia-Qi,Wang Man-Di,Xiao Ting,Wang Yu,Niu Jia-Yuan,Wang Lu,Hou Da-Yong^ORCID,Fu Bo,Liu Zimo,Wang Hao^ORCID,Xu Wanhai^ORCID

Funder

National Key Research and Development Program of China

Key Research and Development Program of Heilongjiang

National Natural Science Foundation of China

National Key Research and Development Program of China Stem Cell and Translational Research

Publisher

Elsevier BV

Reference49 articles.

1. The 2022 updated European association of urology guidelines on the use of adjuvant immune checkpoint inhibitor therapy for renal cell carcinoma;Bedke;Eur. Urol.,2023

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J. Clin.,2021

3. Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma;Atkins;Cancer Treat Rev.,2018

4. Immunotherapy for kidney cancer: status quo and the future;Bedke;Curr. Opin. Urol.,2018

5. Challenges and opportunities in the management of metastatic renal cell carcinoma: combination therapy and the role of cytoreductive surgery;Patel;Curr. Opin. Oncol.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP